American International Group, Inc. Contrafect Corp Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.58 - $4.9 $50,993 - $69,795	-14,244 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.46 - $6.68 $165 - $247	37 Added 0.26%	14,244 $68,000
Q4 2020 Feb 12, 2021	SELL	$5.05 - $6.4 $2,065 - $2,617	-409 Reduced 2.8%	14,207 $72,000
Q3 2020 Nov 04, 2020	BUY	$5.05 - $6.99 $32,193 - $44,561	6,375 Added 77.36%	14,616 $77,000
Q2 2020 Aug 12, 2020	BUY	$4.69 - $7.81 $38,650 - $64,362	8,241 New	8,241 $53,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.